Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.

Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.
复制标题

DOI:
10.1007/s11481-021-09984-5
复制
发表时间:
2021-12
期刊:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
影响因子:
--
通讯作者:
Zhu J
Zhu J
中科院分区:
其他
文献类型:
--
作者:
Quizon PM;Yuan Y;Zhu Y;Zhou Y;Strauss MJ;Sun WL;Zhan CG;Zhu J

文献摘要

参考文献

被引文献

相似文献

HIV-1转录反式激活因子(达特)通过阻断多巴胺的传递,对HIV-1相关性神经认知障碍的发生发展有重要影响。本研究确定了人多巴胺转运蛋白(hDAT)对基础和Tat诱导的多巴胺转运抑制的突变效应。与野生型hDAT相比,D381 L和Y88 F/D206 L/H547 A中[3 H]多巴胺摄取的最大速度(Vmax)降低,D206 L/H547 A中增加,而D206 L中无变化。重组TatR 1 − 86抑制野生型hDAT中多巴胺的摄取,这在DAT突变体(D206 L,D206 L/H547 A和Y88 F/D206 L/H547 A)或突变的TatR 1 − 86(K19 A和C22 G)中减弱,表明Tat-DAT相互作用受到干扰。hDAT对转运蛋白构象的突变效应通过减弱D206 L/H547 A和Y88 F/D206 A/H547 A中锌诱导的增加的[3 H] WIN 35,428结合以及增强D206 L/H547 A中的基础MPP+流出来证明。H547 A诱导的向外开放转运构象状态通过在hDAT背景上增强的对插入的半胱氨酸(I159 C)的MTSET([2-(三甲基铵)乙基]-甲硫基磺酸盐)的可及性来进一步验证。此外,H547 A显示棕榈酰化修饰物诱导的多巴胺摄取抑制相对于野生型hDAT增加,表明H547 A中基础棕榈酰化的变化。这些结果表明,Y88 F,D206 L,和H547 A减弱达特抑制,同时保持DA摄取,提供了深入了解,以确定改善DAT介导的多巴胺能失调的目标。HIV-1达特通过直接变构相互作用抑制突触前末梢上的人多巴胺转运蛋白(hDAT)的多巴胺摄取。预测关键hDAT残基D-H547、D-Y88和D-D206参与HIV-1 Tat-DAT结合。突变这些残基通过破坏Tat-hDAT相互作用减弱这种抑制作用。在线版本包含补充材料,可在10.1007/s11481-021-09984-5获得。
HIV-1 transactivator of transcription (Tat) has a great impact on the development of HIV-1 associated neurocognitive disorders through disrupting dopamine transmission. This study determined the mutational effects of human dopamine transporter (hDAT) on basal and Tat-induced inhibition of dopamine transport. Compared to wild-type hDAT, the maximal velocity (Vmax) of [3H]dopamine uptake was decreased in D381L and Y88F/D206L/H547A, increased in D206L/H547A, and unaltered in D206L. Recombinant TatR1 − 86 inhibited dopamine uptake in wild-type hDAT, which was attenuated in either DAT mutants (D206L, D206L/H547A, and Y88F/D206L/H547A) or mutated TatR1 − 86 (K19A and C22G), demonstrating perturbed Tat-DAT interaction. Mutational effects of hDAT on the transporter conformation were evidenced by attenuation of zinc-induced increased [3H]WIN35,428 binding in D206L/H547A and Y88F/D206A/H547A and enhanced basal MPP+ efflux in D206L/H547A. H547A-induced outward-open transport conformational state was further validated by enhanced accessibility to MTSET ([2-(trimethylammonium)ethyl]-methanethiosulfonate) of an inserted cysteine (I159C) on a hDAT background.. Furthermore, H547A displayed an increase in palmitoylation inhibitor-induced inhibition of dopamine uptake relative to wide-type hDAT, indicating a change in basal palmitoylation in H547A. These results demonstrate that Y88F, D206L, and H547A attenuate Tat inhibition while preserving DA uptake, providing insights into identifying targets for improving DAT-mediated dopaminergic dysregulation. HIV-1 Tat inhibits dopamine uptake through human dopamine transporter (hDAT) on the presynaptic terminal through a direct allosteric interaction. Key hDAT residues D-H547, D-Y88, and D-D206 are predicted to be involved in the HIV-1 Tat-DAT binding. Mutating these residues attenuates this inhibitory effect by disrupting the Tat-hDAT interaction The online version contains supplementary material available at 10.1007/s11481-021-09984-5.
DOI: 10.1016/j.neuroimage.2008.05.011
发表时间: 2008-08-15
期刊: NEUROIMAGE
影响因子: 5.7
作者:
Chang, Linda;Wang, Gene-Jack;Fowler, Joanna S.
通讯作者: Fowler, Joanna S.
DOI: 10.1007/s13365-010-0006-1
发表时间: 2011-02
影响因子: 3.2
作者:
Heaton, Robert K.;Franklin, Donald R.;Ellis, Ronald J.;McCutchan, J. Allen;Letendre, Scott L.;LeBlanc, Shannon;Corkran, Stephanie H.;Duarte, Nichole A.;Clifford, David B.;Woods, Steven P.;Collier, Ann C.;Marra, Christina M.;Morgello, Susan;Mindt, Monica Rivera;Taylor, Michael J.;Marcotte, Thomas D.;Atkinson, J. Hampton;Wolfson, Tanya;Gelman, Benjamin B.;McArthur, Justin C.;Simpson, David M.;Abramson, Ian;Gamst, Anthony;Fennema-Notestine, Christine;Jernigan, Terry L.;Wong, Joseph;Grant, Igor
通讯作者: Grant, Igor
DOI: 10.1016/j.nbd.2017.04.015
发表时间: 2017-09
影响因子: 6.1
作者:
Gaskill PJ;Miller DR;Gamble-George J;Yano H;Khoshbouei H
通讯作者: Khoshbouei H
DOI: 10.1016/j.ejphar.2003.08.068
发表时间: 2003-10-31
影响因子: 5
作者:
Loland, CJ;Norgaard-Nielsen, K;Gether, U
通讯作者: Gether, U
DOI: 10.1007/s11481-013-9464-6
发表时间: 2013-09-01
影响因子: 6.2
作者:
Midde, Narasimha M.;Huang, Xiaoqin;Zhu, Jun
通讯作者: Zhu, Jun